TALPHERA, INC. Increase (Decrease) in Other Operating Assets
TALPHERA, INC. (TLPH) reported Increase (Decrease) in Other Operating Assets of -$226.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-06
- TALPHERA, INC. increase (decrease) in other operating assets for the quarter ending 2023-12-31 was $0.00.
- TALPHERA, INC. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was $0.00.
- TALPHERA, INC. increase (decrease) in other operating assets for the quarter ending 2019-12-31 was -$59.00K.
- TALPHERA, INC. increase (decrease) in other operating assets for the quarter ending 2019-09-30 was -$35.00K.
- TALPHERA, INC. increase (decrease) in other operating assets for fiscal 2023 was -$226.00K.
- TALPHERA, INC. increase (decrease) in other operating assets for fiscal 2022 was $0.00.
- TALPHERA, INC. increase (decrease) in other operating assets for fiscal 2019 was $220.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$226.00K 10-K · filed 2024-03-06 | ||
| 2023-09-30 | -$226.00K 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | |||
| 2019-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$94.00K derived: sum of 2 quarters · filed 2020-03-16 | $220.00K 10-K · filed 2020-03-16 | |
| 2019-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $279.00K 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | $314.00K 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |